CureImmune is developing an immuno-oncology checkpoint inhibitor drug that is a stable small molecule, inexpensive to manufacture, easy to store and ship, and that can be administered at home.
Company (Alive / Active)
Fitzsimmons Bioscience Center
12635 E. Montview Blvd. Suite 100G
Colorado, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)